Minimal but essential doses of immunosuppression: A more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation

Transplantation

Volumn 91, Issue 7, 2011, Pages 809-810

  Ohe, Hidenori ^a   Li, Ying ^b   Nafady Hego, Hanaa ^a   Kayo, Waki ^c   Sakaguchi, Shimon ^b   Wood, Kathryn ^d   Calne, Roy ^e   Uemoto, Shinji ^a   Koshiba, Takaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

CHILD; CLINICAL ARTICLE; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TREATMENT OUTCOME;

CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 79954573210     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31820f07de     Document Type: Letter

References (9)

1. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric livingdonor liver transplantation. Transpl Immunol 2007; 17: 94.
2. Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118.
3. Li Y, Zhao X, Cheng D, et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86: 1837.
4. Takatsuki M, Uemoto S, Inomata Y, et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. Transpl Immunol 2001; 8: 279.
5. Nafady-Hego H, Li Y, Ohe H, et al. The generation of donor-specific CD4- CD25-CD45RA naïve regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation. Transplantation 2010; 90: 1547.
6. Yoshitomi M, Koshiba T, Haga H, et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87: 606.
7. Magee J. Graft fibrosis in stable pediatric liver transplant recipients: What does it mean? Hepatology 2009; 49: 726.
8. Koshiba T, Kitade H, Van Damme B, et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003; 76: 588.
9. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701.